Penumbra Q4 Prel. Revenue Rises
(RTTNews) - Penumbra, Inc. (PEN), a medical devices manufacturer, Thursday reported that its preliminary fourth quarter revenue and full year revenue have increased around 21.4 percent to 22 percent and around 17.3 percent to 17.5 percent respectively.
Preliminary Quarterly revenue grew to the range of $383.0 million to $384.8 million and full year revenue rose to the range of $1,401.3 million to $1,403.1 million.
In pre-market activity, PEN shares were trading at $354.49, up 13.15% on the New York Stock Exchange.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.